This Week in Science

Harvard University's planned academic science center in Allston, Mass., is on "pause," says Science. Only the foundation will be finished. The planned 50,000-square-meter facility was to be home to cutting-edge research in biology, engineering, and medicine. Harvard has lost 30 percent of its endowment and expects to see fewer donations.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Nuffield Council on Bioethics says genetically modifying human embryos could be morally permissible, according to the Guardian.

A new Nature Biotechnology paper reports that CRISPR-Cas9 gene editing can lead to large deletions or complex rearrangements that could be pathogenic.

The Wall Street Journal likens a prototype developed by Synthetic Genomics to a "biological fax machine."

In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.